# FULVESTRANT
> **ANDA205871** · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT PHARMS INC · Approved 2019-08-22
## Drug
- **FDA Application Number:** ANDA205871
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FULVESTRANT
- **Generic name:** Fulvestrant
- **Active ingredients:** FULVESTRANT
- **Dosage form:** SOLUTION
- **Route:** INTRAMUSCULAR
- **Marketing status:** Prescription
- **Sponsor:** SAGENT PHARMS INC
- **First approval:** 2019-08-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205871)
---
*AI Analytics · CC0 1.0*